As UK nears zero Covid deaths, there’s good reason for optimism

Analysis: the vaccine strategy and staggered easing of restrictions have worked well. The next step is crucial

The handling of the coronavirus crisis in the UK has provided few moments to celebrate, but the day we reach zero deaths from the disease will clearly be one to toast. That day may not be far off. On Tuesday, the UK reported four Covid deaths within 28 days of a positive test. On Monday it was only one. Months of painful lockdown, in the face of more transmissible variants, and the rapid rollout of effective vaccines, have proven their worth. We have good reason to feel optimistic for the months ahead.

No one will have forgotten the brutal winter. In January alone, the UK reported nearly 32,000 Covid deaths, an appalling tally directly linked to locking down too late. In April, the death toll fell to 753. This month, scientists advising the government expect deaths to fall further. It is worth remembering that it’s been more than nine months since the UK last reported zero Covid deaths. We may see more in May, though people will continue to die of Covid, and the numbers might well rise again when restrictions are lifted on indoor mixing.

One day doesn’t make for a meaningful milestone. More important is reaching consistently low daily death rates, a goal achieved through a combination of factors. At the start of the year, the lockdown broke chains of transmission and reduced R – the number of people an infected person passes the disease on to, on average. Once R fell below one, the epidemic started to shrink. For example, when R reached 0.8, every 100 cases passed the virus on to only 80 more people, and so the numbers fell. Fewer infections inevitably led to fewer deaths.

But as the vaccination programme swung into action, it took on an increasing share of the heavy lifting. First and foremost, these early shots gave the most vulnerable, and so those most likely to die from Covid, the immune defences to fend off the virus. Second, the shots hampered the spread of the disease, pushing R down even further. Even if vaccinated people become infected, and some can, the amount of virus in the respiratory system is lower, so they are less likely to pass it on.

Death rate

The NHS vaccination programme was designed to protect those most at risk as fast as possible. This decision was key, not least for its simplicity. Jabs went first to those in the top nine priority groups drawn up by the Joint Committee on Vaccination and Immunisation. These included the clinically extremely vulnerable – people on drugs to suppress their immune systems, or those with underlying health conditions, for example – plus everyone aged 50 and over. Together, these 32 million people account for 99% of Covid deaths.

Before the vaccine rollout, public health authorities had only clinical trial data in their hands. They were unsure how effective the shots would be in the real world. The answer has now become clear thanks to a flurry of recent data. The first good news arrived in the form of vaccine uptake rates. At least 95% of those aged 50 and over have received at least one shot, far better than many scientists hope for.

Next came findings on the impressive impact of the vaccines. The ONS found that only a fraction of people in hospital with Covid were admitted more than three weeks after having the shot. It takes two to three weeks for the body to muster a good immune response. The findings came after work from Public Health Scotland showed that hospital admission rates fell sharply a month after a single dose. Further positive news came from Public Health England on the vaccine’s ability to curb the spread of the disease. While unvaccinated people infect about 10% of people in their households, the agency estimates the risk is nearly halved when the original case is vaccinated.

Outbreak modelling submitted to the Scientific Advisory Group for Emergencies (Sage) in March shows that daily Covid deaths could be close to zero in much of May and June, but then rise again in July and August. By how much is up for grabs. The art is to suppress the rise in infections as restrictions ease, by vaccinating more of the population. So far, this balancing act appears to have worked: steps one and two of the roadmap appear to have caused cases to plateau rather than take off again.

The pressing question now is what happens after steps three and four of the roadmap, scheduled for 17 May and 21 June respectively. The mass vaccination of older and more vulnerable people will keep deaths down, but not all will be protected because vaccines are never 100% effective. Many young people won’t be fully vaccinated until later in the year, but it is crucial to get high coverage in these age groups, not only to reduce the chances of infections reaching more vulnerable people, but to spare the younger people themselves from the risk of severe disease or the debilitating impact of long Covid.

Contributor

Ian Sample Science editor

The GuardianTramp

Related Content

Article image
Brazilian Covid variant: what do we know about P1?
What threat does variant that is causing devastation in Brazil pose, and how is it different?

Sarah Boseley Health editor

08, Apr, 2021 @2:14 PM

Article image
UK decision on Covid vaccine boosters expected on Thursday
Javid also says decision imminent on jabs for 12- to 15-year-olds, and children would be allowed final say on whether to have it

Peter Walker and Rowena Mason

08, Sep, 2021 @8:35 AM

Article image
Hundreds get Covid vaccine at East London mosque's pop-up clinic
Mosque serving largest Muslim community in UK seeks to reassure those hesitant about the shot

Harriet Sherwood

07, Feb, 2021 @3:42 PM

Article image
Volunteers hired for clinical trial of Covid vaccine made in Scotland
Valneva hopes to seek approval as soon as summer, paving way for potential booster shots in autumn

Ian Sample Science editor

25, Apr, 2021 @11:01 PM

Article image
‘My mum told me to’: Bolton 16- and 17-year-olds get Covid vaccine
Government plans to offer jabs to all in this age group in England within the next week

Josh Halliday and Niamh McIntyre

16, Aug, 2021 @5:15 PM

Article image
Covid patients in ICU now almost all unvaccinated, says Oxford scientist
Prof Sir Andrew Pollard says most of those infected who are fully vaccinated will experience only mild symptoms

Andrew Gregory Health editor

23, Nov, 2021 @7:00 AM

Article image
UK study on mixing Covid vaccines between jabs to be expanded
Researchers to examine whether mixing vaccines may give longer-lasting immunity against virus

Sarah Marsh

14, Apr, 2021 @6:55 AM

Article image
What has to happen before a Covid vaccine can be used?
News about potential vaccines has been encouraging – but when will they be ready?

Sarah Boseley Health editor

20, Nov, 2020 @5:08 PM

Article image
‘We haven’t finished the job’: JVT reflects on 18 months of Covid
Exclusive: Listen to the experts, says deputy chief medical officer Jonathan Van-Tam, not the celebrities

Nicola Davis Science correspondent

24, Sep, 2021 @10:32 AM

Article image
Scientists whose work enabled mRNA Covid vaccine win medicine Nobel prize
Katalin Karikó and Drew Weissman share £823,000 prize announced by Nobel Assembly at the Karolinska Institute in Stockholm

Linda Geddes Science correspondent

02, Oct, 2023 @12:17 PM